                         SEQUENCE LISTING

<110>  Welcome Receptor Antibodies Pty Ltd
 
<120>  Diagnosis and treatment of brain tumors

<130>  510960

<150>  AU 2010902958
<151>  2010-07-02

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  3470
<212>  DNA
<213>  Homo sapiens

<400>  1
gtgcgcacgt ccgcacctca ccctgcggct gacatctcct gcccaggaga tgggcgctga       60

agcttgagcg cctgagtccc tggagccaca cctgcgaaca ccctttgctt ctattgagct      120

gtgcccagcc gcccagtgac agaattccag gacaaagaga tcttcaaaaa tcaaaaatga      180

ggttcacatt tacaagccgg tgcttggcac tgtttcttct tctaaatcac ccaaccccaa      240

ttcttcctgc cttttcaaat caaacctatc caacaataga gcccaagcca tttctttacg      300

tcgtaggacg aaagaagatg atggatgcac agtacaaatg ctatgaccga atgcagcagt      360

tacccgcata ccaaggagaa ggtccatatt gcaatcgcac ctgggatgga tggctgtgct      420

gggatgacac accggctgga gtattgtcct atcagttctg cccagattat tttccggatt      480

ttgatccatc agaaaaggtt acaaaatact gtgatgaaaa aggtgtttgg tttaaacatc      540

ctgaaaacaa tcgaacctgg tccaactata ctatgtgcaa tgctttcact cctgagaaac      600

tgaagaatgc atatgttctg tactatttgg ctattgtggg tcattctttg tcaattttca      660

ccctagtgat ttccctgggg attttcgtgt ttttcaggag ccttggctgc caaagggtaa      720

ccctgcacaa gaacatgttt cttacttaca ttctgaattc tatgattatc atcatccacc      780

tggttgaagt agtacccaat ggagagctcg tgcgaaggga cccggtgagc tgcaagattt      840

tgcatttttt ccaccagtac atgatggcct gcaactattt ctggatgctc tgtgaaggga      900

tctatcttca tacactcatt gtcgtggctg tgtttactga gaagcaacgc ttgcggtggt      960

attatctctt gggctggggg ttcccgctgg tgccaaccac tatccatgct attaccaggg     1020

ccgtgtactt caatgacaac tgctggctga gtgtggaaac ccatttgctt tacataatcc     1080

atggacctgt catggcggca cttgtggtca atttcttctt tttgctcaac attgtccggg     1140

tgcttgtgac caaaatgagg gaaacccatg aggcggaatc ccacatgtac ctgaaggctg     1200

tgaaggccac catgatcctt gtgcccctgc tgggaatcca gtttgtcgtc tttccctgga     1260

gaccttccaa caagatgctt gggaagatat atgattacgt gatgcactct ctgattcatt     1320

tccagggctt ctttgttgcg accatctact gcttctgcaa caatgaggtc caaaccaccg     1380

tgaagcgcca atgggcccaa ttcaaaattc agtggaacca gcgttggggg aggcgcccct     1440

ccaaccgctc tgctcgcgct gcagccgctg ctgcggaggc tggcgacatc ccaatttaca     1500

tctgccatca ggagctgagg aatgaaccag ccaacaacca aggcgaggag agtgctgaga     1560

tcatcccttt gaatatcata gagcaagagt catctgcttg aatgtgaagc aaacacagca     1620

tcgtgatcac tgagccatca tttcctggga gaaagaccat gcatttaaag tattctccat     1680

cctcccagga accgaacata tcatttgtga agaattattc agtgaatttg tccattgtaa     1740

atctgaagaa agttattctt ggtactgttg ctttgggaga cagtctagga atggagtctc     1800

ccactgcaac ttgtgaactc catcattcat ccaggactga gatgcaaatg tcacagtaat     1860

gcaagcaaag tatcaaagaa aaacaatgaa attgacctag ttcagataca gggtgctcct     1920

tgtcaatact gagccattta tacctttgaa atattaaaat cactgtcaat atttttattt     1980

ttaactctgg attttgaatt agattatttc tgtatttggc tatggatctg atttttaatt     2040

tttttaaatt tcagtcaatt ctgatgttac tgagatgttt taccatcctt acaatgtaaa     2100

ccacatgaac tacgtgacct ctgcaagaca aagcggcttt ctaatagaga gattagtaaa     2160

tatgtgaaga aaaagacctg catttggcag gaagatgtat gctttgaatg caaaagaaat     2220

ttagagtcaa tttgctgaaa acattacatg ctcagcttgg ttttggacaa gcctgtccat     2280

tgggcaggac ctagctgttg taaagaattg gtcttaatgt tgaatgtatt ttggttgctg     2340

atgtttataa actgagaggt cacaaagaat ctatcactaa aaatttttac aaaactgcca     2400

aaaatataat tcttagtgga agacaatact ccctttaaag agagtttgcc actcccctaa     2460

actccaggat ttataaagca aattactcca aggtttataa agcagattac ctcttgccct     2520

tgggtgctat ctagcagtaa aagataaatt tgttgaatat tggtaattaa aagactccac     2580

ataagtccat taactgcttt ccacccagct tcaaagctta aaaagagctc aggcttttcc     2640

aggaagatcc aggagggcta attagaaatc aacttgtggt tgaccgcttg tttcttgtta     2700

ttaccaaaac aggaggggaa aaaattaact gctccaaatt taaccataaa tcaattcatg     2760

tttaacgttt ctcattaaaa tccagtatta tattatcata tctctcttta cttcccagta     2820

taagattttt gaaaatcctg aataaaccag tatcgttact ggcacctgaa attaatttgt     2880

gaatttgcaa cagtaatcag agttaccatt atttaatttg tatgctaaat gaggaggtac     2940

attgaaaccc tccaaatctc cagtctcatc tatgtcatat tttgccactg cctttcagaa     3000

gtgatttagt tgtggaaaga taataaattg atttgttatg gttacatatt tagcgcaccc     3060

agagaaaatt aattatattt ctacagagaa aatgaatttg ggatactaaa gtagtttaag     3120

tctcctttac tgaatgtaag ggggggatcg aaaagaaggt atttttccaa tcacagtgtt     3180

atgtagtatt gttctatttt tgtttacaaa catggaaaac agagtatttc tggcagctgt     3240

ggtacaaatg tgataatata ttgctaaaat attttagatg ttattatgct aatatagtag     3300

gggttgaaga aaacaaaata gcttattata gaattgcaca tagttctgcc caaattatgt     3360

gaaatgctta tgcttgtgta tatgtataaa ttaatacaga gtacgttaaa agcaaaaaga     3420

tgtatatttg catatttttc taaagaaata tattattcat cttttcattc                3470


<210>  2
<211>  474
<212>  PRT
<213>  Homo sapiens

<400>  2

Met Arg Phe Thr Phe Thr Ser Arg Cys Leu Ala Leu Phe Leu Leu Leu 
1               5                   10                  15      


Asn His Pro Thr Pro Ile Leu Pro Ala Phe Ser Asn Gln Thr Tyr Pro 
            20                  25                  30          


Thr Ile Glu Pro Lys Pro Phe Leu Tyr Val Val Gly Arg Lys Lys Met 
        35                  40                  45              


Met Asp Ala Gln Tyr Lys Cys Tyr Asp Arg Met Gln Gln Leu Pro Ala 
    50                  55                  60                  


Tyr Gln Gly Glu Gly Pro Tyr Cys Asn Arg Thr Trp Asp Gly Trp Leu 
65                  70                  75                  80  


Cys Trp Asp Asp Thr Pro Ala Gly Val Leu Ser Tyr Gln Phe Cys Pro 
                85                  90                  95      


Asp Tyr Phe Pro Asp Phe Asp Pro Ser Glu Lys Val Thr Lys Tyr Cys 
            100                 105                 110         


Asp Glu Lys Gly Val Trp Phe Lys His Pro Glu Asn Asn Arg Thr Trp 
        115                 120                 125             


Ser Asn Tyr Thr Met Cys Asn Ala Phe Thr Pro Glu Lys Leu Lys Asn 
    130                 135                 140                 


Ala Tyr Val Leu Tyr Tyr Leu Ala Ile Val Gly His Ser Leu Ser Ile 
145                 150                 155                 160 


Phe Thr Leu Val Ile Ser Leu Gly Ile Phe Val Phe Phe Arg Ser Leu 
                165                 170                 175     


Gly Cys Gln Arg Val Thr Leu His Lys Asn Met Phe Leu Thr Tyr Ile 
            180                 185                 190         


Leu Asn Ser Met Ile Ile Ile Ile His Leu Val Glu Val Val Pro Asn 
        195                 200                 205             


Gly Glu Leu Val Arg Arg Asp Pro Val Ser Cys Lys Ile Leu His Phe 
    210                 215                 220                 


Phe His Gln Tyr Met Met Ala Cys Asn Tyr Phe Trp Met Leu Cys Glu 
225                 230                 235                 240 


Gly Ile Tyr Leu His Thr Leu Ile Val Val Ala Val Phe Thr Glu Lys 
                245                 250                 255     


Gln Arg Leu Arg Trp Tyr Tyr Leu Leu Gly Trp Gly Phe Pro Leu Val 
            260                 265                 270         


Pro Thr Thr Ile His Ala Ile Thr Arg Ala Val Tyr Phe Asn Asp Asn 
        275                 280                 285             


Cys Trp Leu Ser Val Glu Thr His Leu Leu Tyr Ile Ile His Gly Pro 
    290                 295                 300                 


Val Met Ala Ala Leu Val Val Asn Phe Phe Phe Leu Leu Asn Ile Val 
305                 310                 315                 320 


Arg Val Leu Val Thr Lys Met Arg Glu Thr His Glu Ala Glu Ser His 
                325                 330                 335     


Met Tyr Leu Lys Ala Val Lys Ala Thr Met Ile Leu Val Pro Leu Leu 
            340                 345                 350         


Gly Ile Gln Phe Val Val Phe Pro Trp Arg Pro Ser Asn Lys Met Leu 
        355                 360                 365             


Gly Lys Ile Tyr Asp Tyr Val Met His Ser Leu Ile His Phe Gln Gly 
    370                 375                 380                 


Phe Phe Val Ala Thr Ile Tyr Cys Phe Cys Asn Asn Glu Val Gln Thr 
385                 390                 395                 400 


Thr Val Lys Arg Gln Trp Ala Gln Phe Lys Ile Gln Trp Asn Gln Arg 
                405                 410                 415     


Trp Gly Arg Arg Pro Ser Asn Arg Ser Ala Arg Ala Ala Ala Ala Ala 
            420                 425                 430         


Ala Glu Ala Gly Asp Ile Pro Ile Tyr Ile Cys His Gln Glu Leu Arg 
        435                 440                 445             


Asn Glu Pro Ala Asn Asn Gln Gly Glu Glu Ser Ala Glu Ile Ile Pro 
    450                 455                 460                 


Leu Asn Ile Ile Glu Gln Glu Ser Ser Ala 
465                 470                 


<210>  3
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Epitope 1 of human CTR

<400>  3

Asp Ile Pro Ile Tyr Ile Cys His Gln Glu Leu Arg Asn Glu Pro Ala 
1               5                   10                  15      


Asn Asn 
        


<210>  4
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Epitope 2 of human CTR

<400>  4

Pro Ser Glu Lys Val Thr Lys Tyr Cys Asp Glu Lys Gly Val Trp Phe 
1               5                   10                  15      


Lys 
    


<210>  5
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Epitope 3 of human CTR

<400>  5

Phe Ser Asn Gln Thr Tyr Pro Thr Ile Glu Pro Lys 
1               5                   10          


